Fe3 Medical

Fe3 is an early stage company developing a novel transdermal therapy for the treatment of iron deficiency anemia. The approach and technology for Fe3 was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations.

25 million people in the US alone have mild to moderate anemia, making it one of the most prevalent micro-nutrient deficiencies.